Gregory S Pediatric Anesthesia s1

Gregory’s Pediatric Anesthesia

Chapter 29 - References

1. Larsen W, Sherman L, Potter S, Scott WJ. Development of the urogenital system. In: Human Embryology, 3rd edn. New York: Churchill Livingstone, 2001, pp. 265–315.

2. Nelson CP, Dunn RL, Wei JT. Contemporary epidemiology of bladder exstrophy in the United States. J Urol 2005; 173: 1728–31.

3. Michael C, Canning D. Management of exstrophy/epispadias at the Children's Hospital of Philadelphia. J Pediatr Urol 2007; 3: S72 (abstract).

4. Kost-Byerly S, Jackson EV, Yaster M et al. Perioperative anesthetic and analgesic management of newborn bladder exstrophy repair. J Pediatr Urol 2008; 4: 280–5.

5. Brock JW, DeMarco, RT. Bladder and cloacal exstrophy. In: Grosfeld JL (ed) Pediatric Surgery, 6th edn. Philadelphia: Mosby/Elsevier, 2006, pp. 1841–59.

6. Elder JS. Anomalies of the bladder. In: Kliegman R, Nelson WE (eds) Nelson Textbook of Pediatrics, 18th edn. Philadelphia: Saunders, 2007, pp. 1841–69.

7. Woo LL, Thomas JC, Brock JW. Cloacal exstrophy: a comprehensive review of an uncommon problem. J Pediatr Urol 2010; 6: 102–11.

8. Baird AD, Nelson CP, Gearhart JP. Modern staged repair of bladder exstrophy: a contemporary series. J Pediatr Urol 2007; 3: 311–15.

9. Bharati K, Ashish J, Kumar T, Paras K. Anatomical repair of exstrophy bladder. Pediatr Surg Int 2004; 20: 455–9.

10. Gargollo PC, Borer JG, Diamond DA et al. Prospective followup in patients after complete primary repair of bladder exstrophy. J Urol 2008; 180(4 Suppl): 1665–70.

11. Gearhart JP. Bladder exstrophy: staged reconstruction. Curr Opin Urol 1999; 9: 499–506.

12. Kibar Y, Roth CC, Frimberger D, Kropp BP. Our initial experience with the technique of complete primary repair for bladder exstrophy. J Pediatr Urol 2009; 5: 186–9.

13. Kozlowski LJ. The acute pain service nurse practitioner: a case study in the postoperative care of the child with bladder exstrophy. J Pediatr Health Care 2008; 22: 351–9.

14. Phillips TM, Gearhart JP. Primary closure of bladder exstrophy. BJU Int 2009; 104: 1308–22.

15. Bomalaski M. Posterior urethral valves. 2010. http://emedicine.medscape.com/article/1016086–print.

16. Docimo SG, Kelalis PP, King LR, Belman AB. The Kelalis–King–Belman Textbook of Clinical Pediatric Urology, 5th edn. London: Informa Healthcare, 2007.

17. Kliegman R, Nelson WE. Urologic disorders in infants and children. In: Kliegman R, Nelson WE (eds) Nelson Textbook of Pediatrics, 18th edn. Philadelphia: Saunders, 2007, pp. 1359–79.

18. Malik GH. Posterior urethral valves. Prof Med J 2005; 12: 473–9.

19. Baum VC, O'Flaherty JE. (2007) Potter syndrome. In: Baum VC, O'Flaherty JE (eds) Anesthesia for Genetic, Metabolic, and Dysmorphic Syndromes of Childhood, 2nd edn. Philadelphia: Lippincott Williams and Wilkins, p.308.

20. Williams N, Kapila L. Complications of circumcision. Br J Surg 1993; 80: 1231–6.

21. Spear RM, Deshpande JK, Davis PJ. Anesthesia for general, urologic, and plastic surgery. In: Motoyama EK, Davis PJ (eds) Smith's Anesthesia for Infants and Children, 5th edn. St Louis, MO: Mosby, 1996, pp. 591–603.

22. Lammers CR, Hammer GB. Pediatric urology. In: Jaffe RA, Samuels SI (eds) Anesthesiologist's Manual of Surgical Procedures, 3rd edn. Philadelphia: Lippincott Williams and Wilkins, 2004, pp. 1068–82.

23. Bracka A. Hypospadias repair: the two-stage alternative. Br J Urol 1995; 76(Suppl 3): 31–41.

24. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Risk factors for cryptorchidism and hypospadias. J Urol 1999; 161: 1606–9.

25. Berkowitz GS, Lapinski RH, Dolgin SE et al. Prevalence and natural history of cryptorchidism. Pediatrics 1993; 92: 44–9.

26. Berkowitz GS, Lapinski RH, Godbold JH et al. Maternal and neonatal risk factors for cryptorchidism. Epidemiology 1995; 6: 127–31.

27. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 1997; 18: 259–80.

28. Baker LA, Sigman D, Mathews RI et al. An analysis of clinical outcomes using color doppler testicular ultrasound for testicular torsion. Pediatrics 2000; 105(3 Pt 1): 604–7.

29. Matteson JR, Stock JA, Hanna MK et al. Medicolegal aspects of testicular torsion. Urology 2001; 57: 783–7.

30. Chiang D, Ben-Meir D, Pout K, Dewan P. Management of post-operative bladder spasm. J Paediatr Child Health 2005; 41: 56–8.

31. Elder J. Obstruction of the urinary tract. In: Kliegman R, Nelson WE (eds) Nelson Textbook of Pediatrics, 18th edn. Philadelphia: Saunders, 2007, pp. 2234–8.

32. Stern J, Park S, Anderson J et al. Functional assessment of crossing vessels as etiology of ureteropelvic junction obstruction. Urology 2007; 69: 1022–4.

33. Park JM, Bloom DA. The pathophysiology of uereteropelvic junction obstruction. Current concepts. Urol Clin North Am 1998; 25: 161–9.

34. Joyner BD, Mitchel ME. Ureteropelvic junction obstruction. In: Grosfeld JL (ed) Pediatric Surgery, 6th edn. Philadelphia: Mosby/Elsevier, 2006, pp. 1723–40.

35. Tanaka ST, Grantham JA, Thomas JC et al. A comparison of open vs laparoscopic pediatric pyeloplasty using the pediatric health information system database – do benefits of laparoscopic approach recede at younger ages? J Urol 2008; 180: 1479–85.

36. Chamie K, Tanaka ST, Hu B, Kurzrock EA. Short stay pyeloplasty: variables affecting pain and length of stay. J Urol 2008; 179: 1549–52.

37. Ben-Meir D, Livne P, Katz J et al. Continuous epidural versus nonepidural analgesia for post-pyeloplasty pain in children. J Urol 2009; 182(4 Suppl): 1841–4.

38. Li J, Thompson TD, Miller JW et al. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics 2008; 121: e1470–7.

39. Davidoff AM. Wilms' tumor. Curr Opin Pediatr 2009; 21: 357–64.

40. Morgan E, Baum E, Breslow N et al. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. J Clin Oncol 1988; 6: 51–5.

41. Green D, Norkool P, Breslow N et al. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study. J Clin Oncol 1990; 8: 1525–30.

42. Coppes MJ, Tournade MF, Lemerle J et al. Preoperative care of infants with nephroblastoma the international society of pediatric oncology 6 experience. Cancer 1992; 69: 2721–5.

43. Auron A, Brophy P. Pediatric renal supportive therapies: the changing face of pediatric renal replacement approaches. Curr Opin Pediatr 2010; 22: 183–8.

44. Hardison D, Fleming GM. RRT on ECMO. In: Short (ed) ECMO Specialists Training Manual. Ann Arbor, MI: Extracorporeal Life Organization Publishing, 2010, pp. 189–96.

45. Palsson R, Laliberte KA, Niles JL. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration. Clin Nephrol 2006; 65: 34–42.

46. Walters S, Porter C, Brophy P. Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol 2009; 24: 37–48.

47. Zarbock A, Singbartl K, Kellum JA. Evidence-based renal replacement therapy for acute kidney injury. Minerva Anestesiol 2009; 75: 135–9.

48. Palevsky P. Renal replacement therapy I: indications and timing. Crit Care Clin 2005; 21: 347–56.

49. Vogt BA, Avner E. Renal failure. In: Kliegman R, Nelson WE (eds) Nelson Textbook of Pediatrics, 18th edn. Philadelphia: Saunders, 2007, pp. 2206–9.

50. North American Pediatric Renal Trials and Collaborative Studies Annual Report, 2008.

https: //web.emmes.com/study/ped/annlrept/Annual%20Report%20–2008.pdf.

51. Blake PG, Daugirdas JT. Physiology of peritoneal dialysis. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of Dialysis, 4th edn. Philadelphia: Lippincott Williams and Wilkins, 2007, pp. 323–8.

52. Daugirdas JT. Physiologic principles and urea kinetic modeling. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of Dialysis, 4th edn. Philadelphia: Lippincott Williams and Wilkins, 2007, pp. 25–58.

53. McBryde KD, Kershaw DB, Bunchman TE et al. Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 2006; 148: 770–8.

54. Parakininkas D, Greenbaum LA. Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 2004; 5: 269–74.

55. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial 2008; 21: 493–8.

56. Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994; 45: 629–35.

57. Debray D, Yousef N, Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Pediatr Drugs 2006; 8: 1–13.

58. MacLaren G, Butt W. Controversies in paediatric continuous renal replacement therapy. Int Care Med 2009; 35: 596–602.

59. Petroni KC, Cohen NH. Continuous renal replacement therapy: anesthetic implications. Anesth Analg 2002; 94: 1288–97.

60. Fadrowski J, Hwang W, Neu A et al. Patterns of use of vascular catheters for hemodialysis in children in the United States. Am J Kidney Dis 2009; 53: 91–8.

61. Goldstein SL. Advances in renal replacement therapy as a bridge to renal transplantation. Pediatr Transplant 2007; 11: 463–70.

62. Chand D, Valentini R, Kamil E. Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners. Pediatr Nephrol 2009; 24: 1121–8.

63. Cribbs RK, Greenbaum LA, Heiss KF. Risk factors for early peritoneal dialysis catheter failure in children. J Pediatr Surg 2010; 45: 585–9.

64. Argo JL, Yellumahanthi DK, Ballem N et al. Laparoscopic versus open approach for implantation of the peritoneal catheter during ventriculoperitoneal shunt placement. Surg Endosc 2009; 23: 1449–55.

65. Shroff R, Ledermann S. Long-term outcome of chronic dialysis in children. Pediatr Nephrol 2009; 24: 463–74.

66. Khuenl-Brady K, Pomaroli A, Pühringer F et al. The use of rocuronium (ORG 9426) in patients with chronic renal failure. Anaesthesia 2007; 48: 873–5.

67. Wagener G, Brentjens TE. Anesthetic concerns in patients presenting with renal failure. Anesthesiol Clin 2010; 28: 39–54.

68. Wadei H, Davis C. Renal replacement therapy in the liver transplant candidate. Adv Chron Kid Dis 2009; 16: 250–5.

69. Bardin E, Krieger J. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Int Urol Nephrol 1990; 22: 147–52.

70. Montague D, Jarow J, Broderick G et al. American Urological Association guideline on the management of priapism. J Urol 2003; 170: 1318–24.

71. Burnett A. Priapism. In: Campbell MF, Wein AJ, Kavoussi LR (eds) Campbell–Walsh Urology, 9th edn. Philadelphia: Saunders/Elsevier, 2007, pp. 839–50.

72. Bochinski DJ, Lue TF. Priapism. In: Graham SD, Glenn JF (eds) Glenn's Urologic Surgery, 6th edn. Philadelphia: Lippincott Williams and Wilkins, 2005, pp. 554–6.

73. Breslow N, Olshan A, Beckwith JB et al. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993; 21: 172–81.